List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 16 studies with search of:   "EntreMed" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
Conditions: Hematological Malignancies;   Myelodysplasia;   Agnogenic Myeloid Metaplasia
Intervention: Drug: MKC-1
2 Active, not recruiting A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: MKC-1
3 Completed Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Panzem® NCD
4 Active, not recruiting Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma
Interventions: Drug: Panzem® NCD;   Drug: Sunitinib Malate
5 Completed Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: Panzem Nanocrystal Colloidal Dispersion
6 Active, not recruiting Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
Conditions: Advanced Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: MKC-1;   Drug: pemetrexed
7 Completed A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
Condition: Breast Cancer
Intervention: Drug: MKC-1
8 Recruiting Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: MKC-1
9 Completed Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Panzem Nanocrystal Colloidal Dispersion (NCD)
10 Completed Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Recurrent Glioblastoma Multiforme
Interventions: Drug: Panzem NCD;   Drug: Temozolomide
11 Recruiting Phase 1 Study of MKC-1 in Patients With Advanced Cancer
Condition: Advanced Cancer
Intervention: Drug: MKC-1
12 Recruiting Study of ENMD-2076 in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: ENMD-2076
13 Recruiting A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
Condition: Advanced Cancer
Intervention: Drug: ENMD-2076
14 Active, not recruiting A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
Conditions: Relapsed Multiple Myeloma;   Plateau Phase Multiple Myeloma
Intervention: Drug: 2-methoxyestradiol
15 Completed Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: recombinant human Angiostatin protein;   Drug: paclitaxel;   Drug: carboplatin
16 Active, not recruiting A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
Condition: Carcinoid Tumor
Intervention: Drug: Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services